Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone (Q43709832)

26 November 2017

title

Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone (English)

1 reference

26 November 2017

Mansbach RS

1

1 reference

26 November 2017

Carver J

series ordinal

2

1 reference

26 November 2017

Zorn SH

series ordinal

3

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Pharmacology, Biochemistry and Behavior

26 November 2017

published in

1 reference

26 November 2017

volume

69

1 reference

26 November 2017

issue

3-4

1 reference

26 November 2017

page(s)

535-542

1 reference

Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Prestimulus effects on human startle reflex in normals and schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

The effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Elementary neuronal dysfunctions in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Time course of antipsychotic effects of neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Drug treatment of the negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Dopaminergic stimulation disrupts sensorimotor gating in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Disorders of attention and perception in early schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900561-5

7 January 2021

10.1016/S0091-3057(01)00561-5

Identifiers

DOI

1 reference

26 November 2017

1 reference